NCT06207487View on ClinicalTrials.gov

Evaluation of Herpes Zoster Characteristics and Costs in Cancer Population.

Not yet recruitingOBSERVATIONAL

Enrollment

150

Participants

Timeline

Start Date

February 15, 2024

Primary Completion Date

February 29, 2024

Study Completion Date

December 30, 2024

Conditions

Herpes Zoster

All Listed Sponsors

lead

AC Camargo Cancer Center

OTHER

NCT06207487 - Evaluation of Herpes Zoster Characteristics and Costs in Cancer Population. | Biotech Hunter | Biotech Hunter